Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9

First 9 Last

Share
Profile

Follow
Joannie

12,026 Posts.

680

29/10/22

15:59

Post #: 64475063
Share

Originally posted by the w: ↑

wow you have to love RAN. an exciting stock to hold.

lots to love in this report. .... and some concerns, but demonstrates the slow grind ahead. tian should get his mutliples but suspect he wont have the patience required.

biggest thing for me is they need this loan and fast. ideally from an external to build confidence and not a sweetheart deal like the last one. expect there enough in this report that with some added due diligence could get more than one impact investor across the line. look out for cop27 announcement.

indications indo profitability already in outstandings with greater margin again with addition cost savings underway.

biggest thing for me however is managements ability to hold this all together on an oily rag. at the moment cost savings (and revenue opportunities) are all constrained to the current pissy amount of capital on hand and hence requiremnts for almost immediate payback. additional capitalshould open up a whole range longer term but sunstantial benefits.

major concern would be the perenial problem of sales. ran noted this as a disappointment with no real explanation. open to the idea that customer orders may be subdued due to potential delivery delays but this only gets a small part of the way. ultimately all the costs savings are worth nought if there aint any sales.

final comment would be to say australian operations a joke and increasingly a strategic misstep. get the logic of having a foothold in domestic market but really cant see how this provides anythibg of the sought. capital and human resources would ve so much better directed at indo operations.

gltah

Expand

I may have to buy back in again, for the craic.
I remember emailing them some time ago on a Sunday and was pleasantly surprised to get an immediate answer, very nice manager. I cannot remember his name just now.

RAN Price at posting: 0.7¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HAS

Hastings progressing Yangibana to production with lower costs

The iron ore comeback: Can it last?

There are more pages in this discussion • 21 more messages in this thread...

First 9 Last

Add RAN (ASX) to my watchlist

(20min delay)
Last 0.6¢		Change 0.000(0.00%)		Mkt cap ! $5.635M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Hastings progressing Yangibana to production with lower costs

The iron ore comeback: Can it last?

Featured News

Featured News

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9

Top Stories

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Hastings progressing Yangibana to production with lower costs

The iron ore comeback: Can it last?

Featured News

Featured News